MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015

By Marketsandmarkets, PRNE
Thursday, November 11, 2010

DALLAS, November 12, 2010 - The 'Top 10 drug discovery technologies
( -
strategic analysis and global forecasts (2010 to 2015)' analyzes the top 10
drug discovery technologies with respect to market drivers, opportunities and
trends in the diverse geographical regions including North America, Europe,
Asia and rest of the world.

Browse market data tables and in-depth TOC on Top 10 drug discovery
technologies - strategic analysis and global forecasts (2010 to 2015)

Early buyers will receive 10% customization of reports.

The slow growth of the introduction of new blockbuster drugs is a major
concern which the drug development companies are catering to by using these
top technologies. The increasing utilization of HTS in the lead generation
and increasing adoption of the technology by the academia are some of the
prime market boosters for high throughput screening.

The global top 10 drug discovery technologies market is expected to be
around $30.8 billion in 2010 and estimated to reach $54 billion mark in
2015, growing at a CAGR of 11.9% from 2010-2015. The market for high
throughput screening accounts for the largest share with approximately 33% of
the entire market for top 10 drug discovery technologies. This huge market
share is mainly due to the increasing applications of cell based assays and
robotics in the parallel screening of compounds.

    Scope of the report

    This research report includes following drug discovery technologies:

    - High throughput screening (robotics and automation, cell
      based assays, miniaturization, high content screening and ultra high
      throughput screening)
    - Bioanalytical instruments (mass spectrometry, NMR, micro plate
      readers and chemotherapy instruments)
    - Pharmacogenomics
    - Combinatorial chemistry
    - Genomics (functional and structural genomics)
    - Biochips (DNA microarrays, lab on a chip, proteomics microarrays)
    - Bioinformatics
    - Proteomics (2DGE, two hybrid systems, isotope encoding and
      activity based assays)
    - RNAi (siRNA, miRNA, ddRNAi, short hairpin RNAs)
    - Nanotechnology (Atomic force microscopy, nano mass spectroscopy,
      dip pen nanolithography and other nanotechnologies)

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting
company based in the U.S. We publish strategically analyzed market research
reports and serve as a business intelligence partner to Fortune 500 companies
across the world. MarketsandMarkets also provides multi-client reports,
company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials,
automotive and transportation, banking and financial services, biotechnology,
chemicals, consumer goods energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals, semiconductor and electronics,
and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website


    Ms. Sunita
    7557 Rambler Road
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004

Ms. Sunita, 7557 Rambler Road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004, Email: sales at

will not be displayed